<DOC>
	<DOCNO>NCT01800240</DOCNO>
	<brief_summary>Objective : subject compare single dose bioavailability Torrent 's Pioglitazone Hydrochloride Metformin Hydrochloride Tablets 15 mg/850 mg Actoplus Met® ( pioglitazone hydrochloride metformin hydrochloride ) Tablets 15 mg/850 mg Takeda Pharmaceuticals America , Inc. USA . Dosing period study separate washout period 14 day . Study Design : Randomized , Two-Way Crossover , Single-Dose , Open-Label</brief_summary>
	<brief_title>Bioequivalence Study Torrent Pharmaceuticals Ltd 's Pioglitazone Hydrochloride Metformin Hydrochloride Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>The volunteer include study base follow criterion : Sex : male . Age : 18 45 year . Volunteer BMI 1827 ( inclusive ) kg/m2 minimum 50 kg weight . Healthy willing participate study . Volunteer willing adhere protocol requirement provide write informed consent . Nonsmokers smoker smoke less 10 cigarette per day The volunteer exclude study base follow criterion : Clinically relevant abnormality result laboratory screening evaluation . Clinically significant abnormal ECG Chest Xray . Systolic blood pressure le 100 mm Hg 140 mm Hg diastolic blood pressure le 60 mm Hg 90 mm Hg . Pulse rate less 50/minute 100/minute . Oral temperature le 95°P 98.6°P . Respiratory rate le 12/minute 20/minute History allergy test drug drug chemically similar drug investigation . History alcohol drug abuse Positive breath alcohol test Recent history kidney liver dysfunction . History consumption prescribe medication since last 14 day OTC medication since last 07 day begin study . Volunteers suffer chronic illness arthritis , asthma etc . History heart failure . HIV , HCV , HBsAg positive volunteer . Opiate , tetra hydrocannabinol , amphetamine , barbiturate , benzodiazepine , Cocaine positive volunteer base urine test . Volunteers suffer psychiatric ( acute chronic ) illness require medication . Administration study drug period 0 3 month entry study . History significant blood loss due reason , include blood donation past 3 month . History preexist bleed disorder . Existence surgical medical condition , , judgment chief investigator and/or clinical investigator/physician , might interfere absorption , distribution , metabolism excretion drug likely compromise safety volunteer . Inability communicate cooperate due language problem , poor mental development impair cerebral function .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>